US Stock MarketDetailed Quotes
ATXS Astria Therapeutics Inc
- 9.750
- -0.790-7.50%
Close Apr 19 16:00 ET
- 9.940
- +0.190+1.95%
Post 16:04 ET
535.30MMarket Cap-4028P/E (TTM)
10.640High9.484Low1.24MVolume10.420Open10.540Pre Close12.16MTurnover3.44%Turnover RatioLossP/E (Static)54.90MShares16.90052wk High3.62P/B352.35MFloat Cap4.26052wk Low--Dividend TTM36.14MShs Float1017.600Historical High--Div YieldTTM10.97%Amplitude2.360Historical Low9.781Avg Price1Lot Size
About Astria Therapeutics Inc Company
Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.
Company Profile
SymbolATXS
Company NameAstria Therapeutics Inc
Listing DateJun 25, 2015
Issue Price12.00
Founded2008
CEODr. Jill C. Milne, PhD
MarketNASDAQ
Employees59
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address75 State Street,Suite 1400
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02109
Phone1-617-349-1971
Websitehttp://www.astriatx.com
Company Executives
- Name
- Position
- Salary
- Dr. Jill C. Milne, PhD
- Director, President and Chief Executive Officer
- 1.72M
- Benjamin Harshbarger
- Senior Vice President and Chief Legal Officer
- 845.83K
- Andrew Komjathy
- Chief Commercial Officer
- --
- Noah Clauser
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- --
- Andrea Matthews
- Chief Business Officer
- --
- Dr. Christopher Morabito, M.D.
- Chief Medical Officer
- --
- Kenneth M. Bate
- Chairman of the Board
- 99.87K
- Dr. Sunil Agarwal, M.D.
- Director
- --
- Michael D. Kishbauch
- Independent Director
- 63.62K
- Hugh M. Cole
- Independent Director
- 57.37K
- Frederick C. Callori
- Independent Director
- 58.62K
- Dr. Jonathan Violin, M.B.A.,PhD
- Independent Director
- 59.87K
- Dr. Joanne T. Beck, PhD
- Independent Director
- 59.87K
- Gregg Anthony Lapointe, C.P.A.,M.B.A.
- Independent Director
- 69.87K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg